Lamivudine - Prevention of HIV vertical transmission

You are here : Home > Formulary Search > Lamivudine - Prevention of HIV vertical transmission

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red

Formulations :

Oral solution

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

BNF SPC

NHSE

Restrictions / Comments :

Important

Restricted use - prevention of vertical transmission in babies born to HIV-positive mothers. Use as recommended in BHIVA guidelines

Documentation

No records returned.

PAD Profile

ChemicalSubstance :

Lamivudine

Indication :

Prevention of HIV vertical transmission

Group Name :

Keywords :

antiviral, vertical transmission, HIV prophylaxis, mothers, babies, peri-natal

Brand Names Include :

Epivir

Important Information :

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Supporting Documents :

Other Indications

Below are listed other indications that Lamivudine is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Prevention of HIV vertical transmission.

Committee Recommendations (1)

04 Sep 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

These drugs falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.

Clinicians / specialists within the Acute setting should only prescribe in line with their Trust formulary / pharmacy advice.

GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication